Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Acq. announced
CC transcript

KING PHARMACEUTICALS INC (KG) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/08/2011 MW King Pharmaceuticals, Inc. Announces Intent to Voluntarily Delist From the New York Stock Exchange
01/31/2011 MW King Pharmaceuticals, Inc. Announces Offer to Purchase Any and All of Its Outstanding 1 1/4% Convertible Senior Notes Due 2026 Through a Tender Offer
10/13/2010 BW The Law Office of Abe Shainberg is Launching an Investigation into the Possible Breaches of Fiduciary Duty by the Board of King Pharmaceuticals, Inc. in Connection with the Sale of the Company to Pfizer, Inc. – KG
10/12/2010 BW Levetown & Jenkins, LLP Announces an Investigation of the Acquisition of King Pharmaceuticals, Inc. by Pfizer, Inc.
10/12/2010 BW Law Office of Brodsky & Smith, LLC Announces Investigation of King Pharmaceuticals
10/12/2010 BW Finkelstein Thompson LLP Announces Investigation of King Pharmaceuticals Inc.
10/12/2010 BW Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of King Pharmaceuticals, Inc.
10/12/2010 BW Ryan & Maniskas, LLP Announces Investigation of King Pharmaceuticals Inc.
10/12/2010 BW The Law Office of Robbins Umeda LLP Announces an Investigation of the Acquisition of King Pharmaceuticals, Inc. by Pfizer, Inc.
10/12/2010 BW King Pharmaceuticals Buyout Investigated for Shareholders by Goldfarb Branham Law Firm LLP
10/12/2010 BW The Briscoe Law Firm Investigates King Pharmaceuticals, Inc. for Shareholders Concerning the Buy-Out by Pfizer Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy